Behavioral and biochemical effects of pharmacopuncture (ST 36 and ST 25) in obese rats by Mariana Chiste Pontes et al.
RESEARCH ARTICLE Open Access
Behavioral and biochemical effects of
pharmacopuncture (ST 36 and ST 25) in
obese rats
Mariana Chiste Pontes, Lilian Cardoso Heck and Janice Carneiro Coelho*
Abstract
Background: Acupuncture has been reported as a weight loss treatment for obese patients. The use of pharmacopuncture
focusing on behavioral analyses has not yet been studied with the objective of treating obesity. Thus, this study aimed to
assess the biochemical and behavioral effects of using pharmacopuncture techniques in obeseWistar rats.
Methods: The treatments consisted in applying pharmacopuncture at the Zusanli (ST 36) and Tianshu (ST 25) points.
Results:When treatedwith pharmacopuncture, groups HDP36 and HDP25 experienced a reduction in body weight
compared to the controls, whowere also fed a hypercaloric diet. In the alimentary behavior test, latency to feed did not differ
between the groups. However, groups HDP36 and HDP25 consumed a smaller number of cereals bits, which suggests that
inappetence was an effect of the treatment. No difference was found among the groups in the elevated plusmaze test,
which indicates no anxiety action of the points studied. Regarding post mortem perirenal and abdominal fat among the
groups fed a hypercaloric diet, groups HDP36 and HDP25 had lower perirenal fat weight and HDP36 had lower abdominal
fat weight compared to the other groups. Likewise, a reduction in cholesterol 10.1186/s12906-015-0829-7 and glucose levels
was found in groups HDP36 and HDP25 compared to the other groups that were fed a hypercaloric diet, while triglycerides
decreased in subgroup HDP25
Conclusions: In conclusion, the present study showed the efficacy of pharmacopuncture in weight loss of obese rats, as well
as changes in biochemical and behavioral parameters.
Keywords:Obesity, Alimentary behavior, Pharmacopuncture
Background
Obesity and overweight are directly linked to the de-
velopment of a series of chronic disease conditions.
The estimated cost for treatment of this chronic dis-
ease in the USA is currently over 7 % of all health-
care expenses [10].
Obesity prevalence widely varies among different races
and ethnic groups, also being more common in women
[31]. Similarly, socioeconomic level and schooling are
risk factors of overweight and obesity [25].
Therefore, experts are increasingly interested in study-
ing obesity in order to better understand the factors and
processes of this metabolic disorder, proposing solutions
to a problem that affects a large portion of the
population worldwide, regardless of social class, gender,
or age [6].
The changes in lifestyle that lead to a slight weight loss
can, in fact, are beneficial to health. The sustained weight
loss of 3 to 5 % results in clinically significant reductions
in triglycerides, glycemia, and glycated hemoglobin levels,
as well as a lowered risk of developing type 2 diabetes [7].
Further weight losses entails a reduction in arterial
blood pressure, improved lipid levels, and decreased
need for drugs to control blood pressure, glycemia, and
lipid levels [11].
The conventional therapy strategies against obesity do
not result in appropriate weight control among every
treated patient, therefore complementary therapies are
also employed [1, 3].
Acupuncture is one of the oldest healing practices
and is currently the fastest exponentially growing
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complementary therapy recognized by the World Health
Organization [3].
Pharmacopuncture is also known as acupoint injection
or aquapuncture. That means pharmacological medica-
tion is injected to acupoints, a new therapy associating
acupuncture and medication. New finds reported that
pharmacopuncture could provide stronger clinical re-
sponse than traditional acupuncture [27, 16].
The traditional acupuncture has been reported as a
treatment method for weight loss for obese patients
[30, 5]. Nevertheless, its mechanisms are still under
study and there is no behavioral assessment of the
action of pharmacopuncture in obese individuals [28, 3].
Some studies suggest that stimulation by acupuncture
may have an effect even in individuals of normal
weight [13]. Thus, it is important to investigate
which effects occur in individuals of normal weight,
in an attempt to clarify the mechanisms involved in
stimulation through acupuncture.
Therefore, the present study aimed to assess the bio-
chemical and behavioral effects of pharmacopuncture at
acupoints Zusanli (ST 36) and Tianshu (ST 25), as
described by the Traditional Chinese Medicine, in obese
Wistar rats.
Methods
Eighty (80) male Wistar rats, with an average weight of
250 ± 10 g were used in the study. The animals came
from a monogamous Wistar colony maintained using
Poliey heterogeneous breeding method under a con-
trolled conventional sanitary standard at the Bioterium
of the Department of Biochemistry of UFRGS.
The “Principles of Laboratory Animal Care” (NIH
publication n°85- 2, revised 1985) were followed in
all of the experiments and the Ethics Committee for
Animal Research of the Federal University of Rio
Grande do Sul, Porto Alegre approved the experi-
mental protocol.
The breeders of that colony were kept in a standardized
environment in polypropylene cages (414×344×168 mm)
with stainless steel lids and a selected autoclaved pine
shavings bed under a 12 h light/dark photoperiod
(7 AM/7 PM) and controlled temperature (21 °C). The
animals used in this study were kept under the same
conditions with five animals per cage.
Water and food were provided ad libitum for three
months prior to the experiment. The animals were split
into two groups containing 40 specimens each: Group 1
(control), animals with a balanced diet; and Group 2
(obese), obese animals previously treated with a hyperca-
loric diet.
The animals in Group 1 were fed water and a bal-
anced diet ad libitum. Those in Group 2 were fed a
hypercaloric diet (Table 1) throughout the period of
the experiment. The animals were kept on this diet
for 16 weeks (3 months), which led to a significant
weight gain.
At first it was necessary to create an animal obesity
model in Wistar rats. By using a hypercaloric diet, with
excess lipids (vegetable oil) and glycides (condensed
milk), a significantly higher weight gain was possible in
the animals fed this diet compared to the ones fed the
control diet. Battú et al. [2] had already developed this
type of model, which aims to increase animal body
weight, and the present results match the ones found by
those authors.
The two experimental groups were split into sub-
groups containing ten animals each. They were split in:
a group in which the animals received only manipula-
tion, a group in which non –acupuncture points were
used in the animals and two groups in which the
previously mentioned acupuncture points for the treat-
ment of obesity were utilized. The acupoints used were
Zusanli (ST 36) and Tianshu (ST 25). The non-
acupuncture point corresponding to a given acupoint
was chosen based on its signal being less than half of the
conductance measured for that acupoint, laterally to
Zuzanli.
In summary, the subgroups, with ten animals each,
were as follows: SDH (standard diet/manipulation),
SDNO (standard diet non-point), SDP36 (standard diet/
point 36), SDP25 (standard diet/point 25), HDH (hyper-
caloric diet/manipulation), HDNP (hypercaloric diet/
non-point), HDP36 (hypercaloric diet/point 36), and
HDP25 (hypercaloric diet/point 25).
The intervention was performed once a day for
12 weeks, with the application of bee venom (Sigma-
Aldrich®, 0.025 mg/kg) pharmacopuncture, in a con-
centration of 0.01 mg/0.05 ml. Each animal was
administered approximately 0.05 ml, injected subcutane-
ously on side right of the body. The syringe utilized was
0.45×13, with a needle gauge of 26G× ½”. Body weight was
measured prior to and after treatment.











Pontes et al. BMC Complementary and Alternative Medicine  (2015) 15:297 Page 2 of 9
The behavioral parameters were assessed after the acu-
puncture intervention, using the elevated plus maze test
to evaluate anxiety [4] and the alimentary behavior test
to analyze motivation for food intake [24].
The elevated plus maze test consists in having the ani-
mal move about for five minutes in a cross-shaped de-
vice with two open-sided arms and two arms with side
walls that provide apparent protection for the animal.
This test does not require prior exposure of the animal
to the device.
The alimentary behavior test is an analysis of the la-
tency time for the animal to reach a bowl containing 16
units of Froot Loops® with eight different colors, of the
latency time until the first bite to the food, and of the
number of cereal bits consumed. The device consists of
a 50 cm corridor and the animal is placed for three mi-
nutes at the opposite end of the bowl with food. This
test requires a five-day training period so that the animal
can adapt to the device and the new food.
By the end of the pharmacopuncture intervention
period, the animals were weighed and euthanized using
the guillotine method. Blood and fat tissue samples were
collected. Visceral fat (retroperineal and epididymal) was
removed and weighed.
Triglycerides, glucose, and cholesterol were assessed
using specific commercial kits from Labtest (Brazil)
(Triglicérides Liquiform, Glicose PAP Liquiform, and
Colesterol Liquiform, respectively) to determine the final
reaction point in plasma after it was separated from the
blood collected in EDTA tubes by centrifuging at
Fig. 1 Variation in body weight during the weight-gain period. *Significant (p < 0.001) difference when comparing the hypercaloric and standard
diet groups
Fig. 2 Variation in body weight during the treatment period. *Subgroups HDP36 and HDP25 had a significant (p < 0.001) body weight loss
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2.000 rpm for ten minutes. Colorimetric enzymatic
assays were used for all analyses, and performed accord-
ing to the manufacturer’s instructions. The readings
were carried out in a UV–Vis spectrophotometer with
505 nm absorbance for triglycerides and glucose, and
500 nm for cholesterol.
The statistical analysis employed ANOVA for the body
weight variation, body fat weight, and biochemical ana-
lyses, while the Kruskal-Wallis test was used for the be-
havioral analyses, with a 5 % level of significance.
Results and discussion
There are several hurdles in the treatment of obesity; a
disease that has been continuously growing in the mod-
ern world. Among those, it is worth mentioning the lack
of adherence to the conventional treatment with diets
and physical exercise, as well as the adverse effects of
the pharmacological treatment. Acupuncture is a treat-
ment that is being used as a complementary therapy for
obesity [3] and is recognized by the WHO. Just the
same, it has been shown that pharmacopuncture can
be employed more quickly and conveniently than the
original technique [23]. No reports were found in the
literature on the contribution of bee venom pharma-
copuncture for the treatment of obesity in rats. How-
ever, there is a study in humans using non related
acupoints to this study [21, 22]. Therefore, discussing
the results of the effects of pharmacopuncture in
points ST 36 and ST 25 becomes crucial, based on
the results of the present study.
Obesity model
In the three months during which the animals were only
fed the diet provided by us, a significant (p < 0.001)
Fig. 3 Alimentary behavior test
Fig. 4 Alimentary behavior test. *Significant (p < 0.001) difference of subgroups HDP36 and HDP25 compared to the others
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weight gain was observed in those fed the hypercaloric
diet, both in comparison with their initial weight and
with the animals that were fed the standard commercial
diet (Fig. 1). Both groups gained a significant amount of
weight (p < 0.001) over the course of treatment (14.3 %
for the controls and 34.96 % for the experimental ani-
mals), and the experimental (obese) group weighed
19.60 % more than the controls (p < 0.001) by the end of
the treatment.
From the results obtained, we can see that the hyper-
palatable and hypercaloric diet employed in the present
study may be widely used as a model of simple obesity.
It enabled a 30 to 40 % body weight gain compared to
the control diet, as it has been described for other
hypercaloric diets [9, 15].
Variation in body weight
After the model was defined, pharmacopuncture was
used in points ST 36 and ST 25, which had never been
tested with pharmacopuncture before, only with acu-
puncture and electroacupuncture.
Next, the diet was maintained for all groups and
acupuncture interventions were performed for three
months. No significant difference was found in the
groups fed the standard diet during the course of treat-
ment. However, among the groups fed the hypercaloric
diet, a significant (p < 0.001) weight loss was observed in
groups HDP36 and HDP25, which were treated with
acupuncture (Fig. 2).
The positive outcomes of body weight loss from using
pharmacopuncture found in the present study are in
Fig. 5 Elevated Plus Maze test. Time in the open-sided arm
Fig. 6 Post mortem perirenal fat. *Significant (p < 0.001) difference when compared to subgroups HDH and HDNP
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accordance with those obtained with the use of electroacu-
puncture and acupuncture in points ST 36 and ST 25 by
several authors [17, 28, 29, 14, 32, 15, 20, 19, 8, 33, 12].
However, the method of injection in the acupoint had not
been described yet for this type of disorder. Pharmaco-
puncture has shown to be a promising option, both in the
experimental approach, given the easy management, and in
the medical and veterinary clinical practice, once it requires
shorter treatment time in the office.
We found that pharmacopuncture did not affect
weight loss, biochemical or behavioral changes in the an-
imals fed the standard diet, which suggests the need for
a metabolic disorder so that a significant result is ob-
tained by using the traditional Chinese medicine tech-
nique. According to Shiraishi et al. [26], the results in
humans depend on the BMI. Nevertheless, this contrasts
with the results by Kim et al. [13] and Kim et al. [14],
which report a reduction in body weight by using elec-
troacupuncture even in non-obese individuals.
Behavioral assessment
These results may target future studies on neurobehav-
ioral analysis of using pharmacopuncture in points ST
36 and ST 25 in the treatment of diet-induced obesity in
rats.
Alimentary behavior test
No significant difference was found between the groups
studied in alimentary behavior regarding latency to feed
(Fig. 3), i.e., both groups reached the food, on average,
within the same timeframe. Nevertheless, the number of
cereal bits consumed was significantly lower (p < 0.001)
in subgroups HDP36 and HDP25 compared to HDH
and HDNP (Fig. 4).
Based on the data obtained, the points assessed im-
pact the motivation for food consumption, according to
the alimentary behavior test. Although latency to feed
did not differ between the groups, the group treated
with pharmacopuncture consumed fewer cereal bits,
Fig. 7 Post mortem abdominal fat. *Significant (p < 0.001) difference when compared to subgroups HDP25, HDH, and HDNP
Fig. 8 Plasma cholesterol. *Significant (p < 0.001) difference when compared to subgroups HDH and HDNP
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which suggests the treatment resulted in lower appeti-
tive behavior in the animals treated with the specific
points.
Elevated plus maze
The elevated plus maze test did not show a significant
difference among the groups analyzed (Fig. 5). The
present study suggests that points ST 36 and ST 25 did
not impact the animals’ anxiety, as shown by the ele-
vated plus maze test. Anxiety is mentioned as a factor
that favors food intake [3], however, no significant differ-
ence in the elevated plus maze test was found that shows
an effect of this component.
Visceral fat weight
The subgroups fed the standard diet had significantly
less (p < 0.001) perirenal and abdominal fat compared to
the subgroups that were fed the hypercaloric diet.
Likewise, less perirenal fat (p < 0.001) was found in
subgroups HDP36 and HDP25 compared to HDH and
HDNP, which shows an effect of acupuncture in body
weight accumulation (Fig. 6). At the same time, only
subgroup HDP36 had significantly (p < 0.001) lower
abdominal fat weight compared to HDH and HDNP
(Fig. 7).
A reduction in perirenal and abdominal fat was also
observed. This also matches the experiments carried out
with electroacupuncture in point ST 36 in rats [15].
The perirenal fat reduction data obtained in the
present study are promising, since inner fat, which is
harder to be reduced exclusively through dietary re-
striction [3], could be reduced using specific acu-
puncture points.
Biochemical analysis
Significant differences were found in the levels of
glucose and plasma cholesterol when the four subgroups
that were fed a hypercaloric diet were compared amongst
Fig. 9 Plasma glucose. *Significant (p < 0.001) difference when compared to subgroups HDH and HDNP
Fig. 10 Plasma triglycerides. *Significant (p < 0.001) difference when compared to subgroups HDH and HDNP
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themselves. However, no significant difference was found
when compairing the four subgroups that were fed stand-
ard diet. Subgroups HDH36 and HDH25 had significantly
(p < 0.001) lower glucose and cholesterol levels compared
to the ones that were also fed the hypercaloric diet with
no pharmacopuncture intervention (HDH and HDNP).
The reduction in glucose and cholesterol levels in sub-
groups HDH36 and HDH25 was so significant that these
animals did not significantly differ from the ones that were
fed the standard diet (SDM, SDNP, SDP36, and SDP25)
(Figs. 8 and 9).
Regarding triglycerides, only subgroup HDP25 had a sig-
nificant (p < 0.001) reduction in plasma levels compared to
the other ones fed the hypercaloric diet (HDH, HDNP, and
HDP6). No significant difference was found when sub-
group HDP25 was compared with the ones fed the stand-
ard diet (SDM, SDNP, SDP36, and SDP25) (Fig. 10).
It was also observed that using pharmacopuncture in
points ST 36 and ST 25 significantly lowered glucose
and cholesterol levels, and that ST 25 decreased trigly-
ceride levels when compared to the control group.
Yang et al. [32] also observed the same in the treatment
with electroacupuncture in these same points in rats,
Wang et al. [30] in Sprague–Dawley rats, and Lee et al.
[18] in male Wistar rats. On the other hand, Tian et al.
[29] did not find differences in plasma glucose and trigly-
ceride levels of Sprague–Dawley rats when using electroa-
cupuncture in point ST 36.
In conclusion, the results hereby presented from the
use of pharmacopuncture in obese Wistar rats show that
this technique may likely be recommended as a comple-
ment in the treatment of patients with high cholesterol,
glucose, and triglyceride levels.
Conclusions
The present study allows a conclusion that pharmaco-
puncture in points ST 36 and ST 25 yields favorable
results in reducing body weight, visceral fat, and bio-
chemical parameters such as cholesterol, triglycerides,
and glucose in obese rats. Likewise, it decreases appeti-
tive behavior as shown by the alimentary behavior test.
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